Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda

BACKGROUND: Ugandan national guidelines recommend initiation of combination antiretroviral therapy (cART) at CD4(+) T cell (CD4) count below 350 cell/μl, but the implementation of this is limited due to availability of medication. However, cART initiation at higher CD4 count increases survival, albe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sempa, Joseph, Ssennono, Mark, Kuznik, Andreas, Lamorde, Mohammed, Sowinski, Stefanie, Semeere, Aggrey, Hermans, Sabine, Castelnuovo, Barbara, Manabe, Yukari C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491016/
https://www.ncbi.nlm.nih.gov/pubmed/22943068
http://dx.doi.org/10.1186/1471-2458-12-736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491016/
https://www.ncbi.nlm.nih.gov/pubmed/22943068
http://dx.doi.org/10.1186/1471-2458-12-736

Ejemplares similares